Dignitana Financial Statements From 2010 to 2025
| DIZTFDelisted Stock | USD 0.22 0.00 0.00% |
Check Dignitana financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dignitana's main balance sheet or income statement drivers, such as , as well as many indicators such as . Dignitana financial statements analysis is a perfect complement when working with Dignitana Valuation or Volatility modules.
Dignitana |
Dignitana AB Company Current Valuation Analysis
Dignitana's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Dignitana Current Valuation | 37.77 M |
Most of Dignitana's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dignitana AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Dignitana AB has a Current Valuation of 37.77 M. This is 99.74% lower than that of the Healthcare sector and 99.7% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 99.77% higher than that of the company.
Dignitana AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dignitana's current stock value. Our valuation model uses many indicators to compare Dignitana value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dignitana competition to find correlations between indicators driving Dignitana's intrinsic value. More Info.Dignitana AB is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dignitana's earnings, one of the primary drivers of an investment's value.About Dignitana Financial Statements
Dignitana stakeholders use historical fundamental indicators, such as Dignitana's revenue or net income, to determine how well the company is positioned to perform in the future. Although Dignitana investors may analyze each financial statement separately, they are all interrelated. For example, changes in Dignitana's assets and liabilities are reflected in the revenues and expenses on Dignitana's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Dignitana AB. Please read more on our technical analysis and fundamental analysis pages.
Dignitana AB , a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. The company was incorporated in 2007 is headquartered in Lund, Sweden. Dignitana is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Dignitana Pink Sheet
If you are still planning to invest in Dignitana AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dignitana's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |